Bevacizumab in combination with irinotecan plus fluorouracil plus leucovorin chemotherapy prolongs survival but increases adverse events in people with metastatic colorectal cancer

Michael A. Choti

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)715-720
Number of pages6
JournalCancer Treatment Reviews
Volume30
Issue number8
DOIs
StatePublished - Dec 2004

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this